Lombard Odier Asset Management (USA)’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-75,000
| Closed | -$2.44M | – | 196 |
|
|
2016
Q2 | $2.44M | Sell |
75,000
-20,000
| -21% | -$649K | 0.29% | 83 |
|
|
2016
Q1 | $2.66M | Buy |
+95,000
| New | +$2.66M | 0.36% | 97 |
|
|
2015
Q2 | – | Sell |
-46,044
| Closed | -$1.5M | – | 175 |
|
|
2015
Q1 | $1.5M | Buy |
+46,044
| New | +$1.5M | 0.12% | 128 |
|
|
2014
Q4 | – | Sell |
-225,000
| Closed | -$5.57M | – | 169 |
|
|
2014
Q3 | $5.57M | Buy |
225,000
+25,000
| +13% | +$619K | 0.38% | 75 |
|
|
2014
Q2 | $4.52M | Buy |
200,000
+100,000
| +100% | +$2.26M | 0.24% | 96 |
|
|
2014
Q1 | $2.43M | Hold |
100,000
| – | – | 0.09% | 140 |
|
|
2013
Q4 | $2.5M | Hold |
100,000
| – | – | 0.11% | 116 |
|
|
2013
Q3 | $2.75M | Sell |
100,000
-100,000
| -50% | -$2.75M | 0.14% | 92 |
|
|
2013
Q2 | $3.63M | Buy |
+200,000
| New | +$3.63M | 0.2% | 89 |
|